Luigi Mangione admitted Friday to shooting and killing Brian Thompson, the chief executive officer of UnitedHealthcare, during a federal court appearance in New York. Mangione, 28 years old, told the judge he shot Thompson on the morning of December 4, 2024, in Manhattan, adding that he knew his actions were illegal. The admission came after Mangione pleaded guilty to federal charges related to stalking the victim, marking a pivotal moment in the case that has drawn national attention. The incident occurred on December 4, 2024, when Thompson was fatally shot during a conference in New York City. Surveillance footage captured the attack, which led to Mangione's eventual arrest. He fled the scene initially but was apprehended on December 9, 2024, in Altoona, Pennsylvania, following a tip from employees at a McDonald’s restaurant where he was located. Prior to the crime, Mangione had traveled to New York by bus from Atlanta, Georgia, approximately ten days earlier. He had reserved a room at a hostel in Manhattan using fake identification and conducted surveillance near the victim’s hotel and the conference location. Mangione’s plea of guilty to federal charges includes stalking and other related offenses. However, he previously entered a not-guilty plea to state-level murder charges in New York. Federal prosecutors announced they would seek life imprisonment during a press conference, while two additional federal charges that could have carried the death penalty were dismissed earlier this year by a judge. At the state level, Mangione faces separate murder charges with a potential life sentence. His trial is set to begin on September 8, though his attorneys are attempting to legally prevent a double prosecution, arguing that the federal plea agreement should bar him from being tried twice for the same act. In the United States, defendants can face both state and federal charges for the same crime, often leading to different legal proceedings. This case has further divided an already polarized American public, with conservative supporters, including former President Donald Trump, calling for severe punishment. Conversely, some citizens view Mangione as a critic of the healthcare insurance industry, which they believe prioritizes profit over patient care. During Mangione’s recent court appearances, supporters have attended in large numbers, with one man shouting “America loves Luigi” as relatives of Thompson left the courthouse in black SUVs. Following his arrest, law enforcement searched Mangione and reviewed his personal belongings, which included a firearm and a silencer. Mangione admitted in court that he used a 3D printer to manufacture the weapon and equipped it with a silencer and a magazine. His confession detailed the circumstances surrounding the attack, providing insight into the methodical planning behind the crime. The sentencing hearing for the federal charges is scheduled for December 18. Meanwhile, the state trial looms as a critical phase in the legal process. Mangione’s legal team continues to challenge the possibility of dual prosecution, citing constitutional protections against double jeopardy. The outcome of these proceedings will determine the severity of the penalties Mangione faces, whether under federal or state jurisdiction. The case has sparked widespread debate about the role of private healthcare companies, the effectiveness of gun control measures, and the legal system’s ability to handle high-profile cases involving complex jurisdictional issues. As the trials approach, the nation watches closely, awaiting developments that could shape the future of both the accused and the broader discourse around corporate accountability and criminal justice.
★
Keep the news honest.
ObjectiveNews is reader-funded and ad-free — we show you the bias instead of hiding it. Support independent journalism for €4/month.
Become a Supporter
France
